Back

The Rapidly Changing Treatment Landscape in the Management of Atopic Dermatitis-A Place in Therapy for OX40-OX40L Inhibitors

This online, on-demand virtual symposium brings together renowned experts in atopic dermatitis (AD). In this educational program, these experts discuss the role of the OX40 and OX40 ligand (OX40L) pathway in the development of atopic dermatitis and how this pathway represents a promising therapeutic target for the complex treatment of atopic dermatitis. This educational activity is an archive of the live symposium held on June 18, 2026.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Jun 30, 2026
  • Last day to claim credit
    Jul 1, 2027 9 months left